Chinese startups Cure Genetics and Frametact ink $60 M deal to develop gene therapy for familial neurological diseases – Biospectrumasia
Chinabased startup Cure Genetics and Frametact, founded by a molecular neuroscience research team at The Hong Kong University of Science and Technology and Hong Kong Center For Neurodegenerative Diseases, have jointly announce the signing of a collaborative development and licensing agreement.